Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries.
about
A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessmentNanoinformatics workshop report: current resources, community needs and the proposal of a collaborative framework for data sharing and information integrationImplementation of alternative test strategies for the safety assessment of engineered nanomaterialsCurrent situation on the availability of nanostructure-biological activity data.Physicochemical signatures of nanoparticle-dependent complement activation.Nano(Q)SAR: Challenges, pitfalls and perspectives.A Review of Recent Advances towards the Development of (Quantitative) Structure-Activity Relationships for Metallic Nanomaterials.Accurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches.A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity.Association rule mining of cellular responses induced by metal and metal oxide nanoparticles.Development of structure-activity relationship for metal oxide nanoparticles.Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis.Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.Probing the toxicity of nanoparticles: a unified in silico machine learning model based on perturbation theory.Use of metal/metal oxide spherical cluster and hydroxyl metal coordination complex for descriptor calculation in development of nanoparticle cytotoxicity classification model.Toxicity Classification of Oxide Nanomaterials: Effects of Data Gap Filling and PChem Score-based Screening Approaches.Towards a generalized toxicity prediction model for oxide nanomaterials using integrated data from different sources.Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles
P2860
Q23909862-21E5EE47-D139-433B-BD68-B5705501E5C1Q23921579-B0F37AEA-9924-46AC-9C6C-42967B45E1E4Q28390126-6F289AF5-B4D2-46B1-839A-ACF0634609E3Q30885444-969D5410-DB11-4476-B40A-4ABF0E9380CAQ34218533-FADBAC88-4115-47DB-BC57-1AE4AD8EDA07Q38248366-7F82B67B-7944-48CB-8254-FDBE0368FDF8Q38600120-900E4C38-486A-4E36-9C49-64967BCB6B28Q38787849-86883B96-74CB-46A9-B7D4-10D99AF973F6Q38933494-8CC7E1C8-F87E-4513-A141-D5ED80245D7BQ38974889-D9AEC2CA-0750-4189-AA25-C1DA063C4102Q39059539-516558E5-9932-4235-A37F-CCD060F485C1Q39149585-9DB05652-DF2C-4AE0-8A8C-9BE1A007707AQ39702398-4D17A015-A6F0-4FF9-AE0C-7B745F3C922FQ40955960-BB1289AA-1ACC-4AF6-B802-23CC8D469CDAQ45945538-64DCA9EB-E0F4-4B0F-822A-B51943D9874BQ47300024-65C34889-B95E-48B5-86BE-795ACAC6AC94Q49912677-838CC851-F14B-455E-9E25-C3DCF93230FBQ55509121-94EEBA03-53D2-4D07-96E0-D890B716CCE4Q57008609-51235FC6-C49F-46BE-ACCB-E8F6286FEBA2
P2860
Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Nano-SAR development for bioac ...... ations of decision boundaries.
@en
Nano-SAR development for bioac ...... ations of decision boundaries.
@nl
type
label
Nano-SAR development for bioac ...... ations of decision boundaries.
@en
Nano-SAR development for bioac ...... ations of decision boundaries.
@nl
prefLabel
Nano-SAR development for bioac ...... ations of decision boundaries.
@en
Nano-SAR development for bioac ...... ations of decision boundaries.
@nl
P2093
P2860
P356
P1433
P1476
Nano-SAR development for bioac ...... ations of decision boundaries.
@en
P2093
Carlos Tassa
Robert Rallo
Stanley Shaw
P2860
P304
P356
10.1002/SMLL.201201903
P577
2013-02-19T00:00:00Z